These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1360164)

  • 1. Raclopride decreases sucrose intake of rat pups in independent ingestion tests.
    Tyrka A; Gayle C; Smith GP
    Pharmacol Biochem Behav; 1992 Nov; 43(3):863-9. PubMed ID: 1360164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCH23390, but not raclopride, decreases intake of intraorally infused 10% sucrose in adult rats.
    Tyrka A; Smith GP
    Pharmacol Biochem Behav; 1993 May; 45(1):243-6. PubMed ID: 8516366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency of SCH 23390 for decreasing sucrose intake in rat pups depends on mode of ingestion.
    Tyrka A; Smith GP
    Pharmacol Biochem Behav; 1991 Aug; 39(4):955-61. PubMed ID: 1837153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raclopride reduces sucrose preference in rats.
    Hsiao S; Smith GP
    Pharmacol Biochem Behav; 1995 Jan; 50(1):121-5. PubMed ID: 7700947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone decreases intake of 10% sucrose in preweanling rats.
    Philopena J; Greenberg D; Smith GP
    Pharmacol Biochem Behav; 1996 Jun; 54(2):333-7. PubMed ID: 8743592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory potency of SCH 23390 and raclopride on licking for sucrose increases across brief-access tests.
    Smith GP; Smith JC
    Physiol Behav; 2010 Oct; 101(3):315-9. PubMed ID: 20515702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar effect of raclopride and reduced sucrose concentration on the microstructure of sucrose sham feeding.
    Schneider LH; Davis JD; Watson CA; Smith GP
    Eur J Pharmacol; 1990 Sep; 186(1):61-70. PubMed ID: 2282936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potency of D-1 and D-2 receptor antagonists is inversely related to the reward value of sham-fed corn oil and sucrose in rats.
    Weatherford SC; Greenberg D; Gibbs J; Smith GP
    Pharmacol Biochem Behav; 1990 Oct; 37(2):317-23. PubMed ID: 2150443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for D2, but not D1, dopamine receptors in the response-reinstating effects of food reinforcement.
    Chausmer AL; Ettenberg A
    Pharmacol Biochem Behav; 1997 Aug; 57(4):681-5. PubMed ID: 9258994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of the effects of raclopride on sucrose consumption by the 5-HT2 antagonist ritanserin.
    Montgomery AM; Suri A
    Psychopharmacology (Berl); 1996 Jan; 123(1):98-102. PubMed ID: 8741960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intraaccumbens injections of dopamine agonists and antagonists on sucrose and sucrose-ethanol reinforced responding.
    Hodge CW; Samson HH; Tolliver GA; Haraguchi M
    Pharmacol Biochem Behav; 1994 May; 48(1):141-50. PubMed ID: 7913224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reward-dependent suppression or facilitation of consummatory behaviour by raclopride.
    Phillips G; Willner P; Muscat R
    Psychopharmacology (Berl); 1991; 105(3):355-60. PubMed ID: 1798832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions.
    Corwin RL; Wojnicki FH
    Behav Pharmacol; 2009 Sep; 20(5-6):537-48. PubMed ID: 19724193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraaccumbens raclopride attenuates amphetamine-induced locomotion, but fails to prevent the response-reinstating properties of food reinforcement.
    Chausmer A; Ettenberg A
    Pharmacol Biochem Behav; 1999 Feb; 62(2):299-305. PubMed ID: 9972697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infra-additivity of combined treatments with selective D1 and D2 receptor antagonists for inhibiting sucrose reinforcement.
    Schneider LH; Watson CA; Gibbs J; Smith GP
    Brain Res; 1991 May; 550(1):122-4. PubMed ID: 1832327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression or facilitation of operant behaviour by raclopride dependent on concentration of sucrose reward.
    Phillips G; Willner P; Muscat R
    Psychopharmacology (Berl); 1991; 105(2):239-46. PubMed ID: 1839065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant.
    D'Aquila P; Monleon S; Borsini F; Brain P; Willner P
    Eur J Pharmacol; 1997 Dec; 340(2-3):121-32. PubMed ID: 9537806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of microinjection of the D2 dopamine antagonist raclopride into the ventral tegmental area on ethanol and sucrose self-administration.
    Samson HH; Chappell AM
    Alcohol Clin Exp Res; 1999 Mar; 23(3):421-6. PubMed ID: 10195813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat.
    Nakajima S; O'Regan NB
    Pharmacol Biochem Behav; 1991 Jun; 39(2):465-8. PubMed ID: 1682950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesogenic diets may differentially alter dopamine control of sucrose and fructose intake in rats.
    Pritchett CE; Hajnal A
    Physiol Behav; 2011 Jul; 104(1):111-6. PubMed ID: 21549729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.